Hubei Bio-pharmaceutical Industrial Technological Institute Inc.
Clinical trials sponsored by Hubei Bio-pharmaceutical Industrial Technological Institute Inc., explained in plain language.
-
New ointment for Sun-Damaged skin spots enters early human testing
Symptom relief Recruiting nowThis early-stage study tests an ointment called HW211026 in 40 adults with actinic keratosis, a common skin condition caused by sun damage. The main goal is to check if the ointment is safe and how the body handles it. Participants will apply the ointment once or several times, a…
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:20 UTC
-
New drug candidate takes first step toward lung disease treatment
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called HW241045 in 56 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects. This is a necessary first step before testing the drug in people with a lung con…
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC